TNF-alpha (APC1, Cachectin, Differentiation inducing factor, DIF, Macrophage cytotoxic factor, MCF, Necrosin, TNF alpha, TNF Macrophage Derived, TNF Monocyte Derived, TNF Superfamily Member 2, TNFA, TNFSF2, Tumor necrosis factor ligand Superfamily member
Cat# MBS6124548-0,1mL
Size : 0.1mL
Brand : MyBiosource
TNF-alpha Antibody – Mouse Monoclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS6124548MBS6124548 is an antibody targeting TNF-alpha. Also known as TNF-alpha (APC1, Cachectin, Differentiation inducing factor, DIF, Macrophage cytotoxic factor, MCF, Necrosin, TNF alpha, TNF Macrophage Derived, TNF Monocyte Derived, TNF Superfamily Member 2, TNFA,… More details
Product Overview
Online Datasheet in PDFProduct Name
TNF-alpha, Monoclonal Antibody
Full Product Name
TNF-alpha (APC1, Cachectin, Differentiation inducing factor, DIF, Macrophage cytotoxic factor, MCF, Necrosin, TNF alpha, TNF Macrophage Derived, TNF Monocyte Derived, TNF Superfamily Member 2, TNFA, TNFSF2, Tumor necrosis factor ligand Superfamily member
Product Gene Name
anti-TNF-alpha antibody
Product Synonym Names
APC1; Cachectin; Differentiation inducing factor; DIF; Macrophage cytotoxic factor; MCF; Necrosin; TNF alpha; TNF Macrophage Derived; TNF Monocyte Derived; TNF Superfamily Member 2; TNFA; TNFSF2; Tumor necrosis factor ligand superfamily member 2; Tumor Necrosis Factor Precursor
Clonality
Monoclonal
Isotype
IgG1,k
Clone Number
SPM543
Host
Mouse
Species Reactivity
Canine, Feline, Human, Mouse, Rabbit, Rat, Zebrafish
Form/Format
Supplied as a liquid in 10mM PBS. No preservative added. BSA-Free. Labeled with Biotin.
Purity/Purification
Purified by Protein A/G Affinity Chromatography.
Specificity
Recognizes TNF-alpha. Species Crossreactivity: Human, Mouse, Rat, Rabbit, Feline, Canine and Zebrafish.
Preparation and Storage
Store product at 4 degree C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20 degree C. Aliquots are stable at -20 degree C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Molecular Weight
25,644 Da
Chromosome Location
Chromosome: 6; NC_000006.11 (31543344..31546113). Location: 6p21.3
OMIM
191160
Immunogen
A hexadecapeptide corresponding to aa115-130 of human TNF-alpha, conjugated to thyroglobulin. Cellular Localization: Cytoplasmic and extracellular (secreted)
Conjugate
Biotin
Positive Control
HeLa, HL-60, or A431 cells. Macrophages in lymph node or Tonsil
Product Categories/Family for anti-TNF-alpha antibody
Antibodies; Growth Factors; Cytokines
Applications Tested/Suitable for anti-TNF-alpha antibody
ELISA (EIA), Flow Cytometry (FC/FACS), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blot (WB)
Application Notes for anti-TNF-alpha antibody
IP: 1-2ug/500ug protein
FC/FACS: 0.5-1ug/million cells
IF: 1-2ug/ml
Applications are based on unconjugated antibody.
FC/FACS: 0.5-1ug/million cells
IF: 1-2ug/ml
Applications are based on unconjugated antibody.
Product References and Citations for anti-TNF-alpha antibody
1. Bebok Z; Markus B; Nemeth P. Prognostic relevance of transforming growth factor alpha (TGF-alpha) and tumor necrosis factor alpha (TNF-alpha) detected in breast cancer tissues by immunohistochemistry. Breast Cancer Research and Treatment, 1994, 29(3):229-35. 2. Bebok Z; Szekeres G; Horvath G; Duda E; Nemeth P. [Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use]. Orvosi Hetilap, 1993 Jun 13, 134(24):1303-7. Language: Hungarian.
Other Notes
Small volumes of anti-TNF-alpha antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for TNF-alpha. It may not necessarily be applicable to this product.
NCBI Official Full Name
tumor necrosis factor
NCBI Official Synonym Full Names
tumor necrosis factor
NCBI Official Symbol
TNF
NCBI Official Synonym Symbols
DIF; TNFA; TNFSF2; TNF-alpha
UniProt Protein Name
Tumor necrosis factor
UniProt Synonym Protein Names
Cachectin; TNF-alpha; Tumor necrosis factor ligand superfamily member 2; TNF-aCleaved into the following 6 chains:Tumor necrosis factor, membrane form; Alternative name(s):; N-terminal fragment
Protein Family
Tumor necrosis factor alpha-induced protein
UniProt Gene Name
TNF
UniProt Synonym Gene Names
TNFA; TNFSF2; TNF-a; NTF; ICD1; ICD2
UniProt Entry Name
TNFA_HUMAN
NCBI Protein Information
tumor necrosis factor; TNF-a; cachectin; APC1 protein; TNF, monocyte-derived; TNF, macrophage-derived; tumor necrosis factor-alpha; tumor necrosis factor ligand superfamily member 2
NCBI Summary for TNF-alpha
This gene encodes a multifunctional proinflammatory cytokine that belongs to the tumor necrosis factor (TNF) superfamily. This cytokine is mainly secreted by macrophages. It can bind to, and thus functions through its receptors TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. This cytokine is involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. This cytokine has been implicated in a variety of diseases, including autoimmune diseases, insulin resistance, and cancer. Knockout studies in mice also suggested the neuroprotective function of this cytokine. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for TNF-alpha
TNF-a: Cytokine that binds to TNFRSF1A/TNFR1 and TNFRSF1B/TNFBR. It is mainly secreted by macrophages and can induce cell death of certain tumor cell lines. It is potent pyrogen causing fever by direct action or by stimulation of interleukin-1 secretion and is implicated in the induction of cachexia, Under certain conditions it can stimulate cell proliferation and induce cell differentiation. Homotrimer. Interacts with SPPL2B. Belongs to the tumor necrosis factor family.
Protein type: Cytokine; Membrane protein, integral; Motility/polarity/chemotaxis; Apoptosis
Chromosomal Location of Human Ortholog: 6p21.3
Cellular Component: extracellular space; recycling endosome; cell surface; integral to plasma membrane; plasma membrane; extracellular region; phagocytic cup; lipid raft; external side of plasma membrane
Molecular Function: identical protein binding; protein binding; protease binding; cytokine activity; tumor necrosis factor receptor binding
Biological Process: positive regulation of JNK activity; extracellular matrix organization and biogenesis; positive regulation of nitric oxide biosynthetic process; positive regulation of NFAT protein import into nucleus; activation of MAPK activity; positive regulation of osteoclast differentiation; positive regulation of apoptosis; positive regulation of transcription, DNA-dependent; response to glucocorticoid stimulus; positive regulation of caspase activity; positive regulation of NF-kappaB import into nucleus; osteoclast differentiation; positive regulation of translational initiation by iron; positive regulation of membrane protein ectodomain proteolysis; activation of NF-kappaB transcription factor; positive regulation of MAP kinase activity; tumor necrosis factor-mediated signaling pathway; positive regulation of phagocytosis; negative regulation of interleukin-6 production; JNK cascade; negative regulation of osteoblast differentiation; positive regulation of action potential; embryonic gut development; regulation of immunoglobulin secretion; negative regulation of protein complex disassembly; response to drug; positive regulation of cytokine production; positive regulation of heterotypic cell-cell adhesion; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of mitosis; response to virus; positive regulation of interleukin-8 biosynthetic process; glucose metabolic process; positive regulation of interleukin-6 production; negative regulation of fat cell differentiation; positive regulation of chemokine production; negative regulation of cytokine secretion during immune response; positive regulation of protein transport; cell activation; detection of mechanical stimulus involved in sensory perception of pain; defense response to Gram-positive bacterium; DNA damage response, signal transduction resulting in induction of apoptosis; induction of apoptosis via death domain receptors; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; response to activity; negative regulation of L-glutamate transport; negative regulation of transcription, DNA-dependent; skeletal muscle contraction; sequestering of triacylglycerol; positive regulation of smooth muscle cell proliferation; negative regulation of transcription from RNA polymerase II promoter; positive regulation of interleukin-18 production; chronic inflammatory response to antigenic stimulus; positive regulation of synaptic transmission; response to salt stress; positive regulation of hair follicle development; negative regulation of cell proliferation; response to radiation; negative regulation of lipid catabolic process; positive regulation of neuron apoptosis; lipopolysaccharide-mediated signaling pathway; protein kinase B signaling cascade; positive regulation of chronic inflammatory response to antigenic stimulus; regulation of I-kappaB kinase/NF-kappaB cascade; inflammatory response; caspase activation; positive regulation of humoral immune response mediated by circulating immunoglobulin; positive regulation of protein complex disassembly; transformed cell apoptosis; calcium-mediated signaling; MAPKKK cascade; positive regulation of peptidyl-serine phosphorylation; humoral immune response; positive regulation of protein kinase B signaling cascade; positive regulation of programmed cell death; positive regulation of interferon-gamma production; negative regulation of glucose import; positive regulation of protein complex assembly; positive regulation of chemokine biosynthetic process; negative regulation of viral genome replication; protein import into nucleus, translocation; positive regulation of protein kinase activity; activation of MAPKKK activity; response to hypoxia; positive regulation of fever; receptor biosynthetic process; positive regulation of protein amino acid phosphorylation; leukocyte tethering or rolling; negative regulation of myoblast differentiation; regulation of insulin secretion; positive regulation of cytokine secretion
Disease: Asthma, Susceptibility To; Migraine With Or Without Aura, Susceptibility To, 1; Malaria, Susceptibility To
Show more Protein type: Cytokine; Membrane protein, integral; Motility/polarity/chemotaxis; Apoptosis
Chromosomal Location of Human Ortholog: 6p21.3
Cellular Component: extracellular space; recycling endosome; cell surface; integral to plasma membrane; plasma membrane; extracellular region; phagocytic cup; lipid raft; external side of plasma membrane
Molecular Function: identical protein binding; protein binding; protease binding; cytokine activity; tumor necrosis factor receptor binding
Biological Process: positive regulation of JNK activity; extracellular matrix organization and biogenesis; positive regulation of nitric oxide biosynthetic process; positive regulation of NFAT protein import into nucleus; activation of MAPK activity; positive regulation of osteoclast differentiation; positive regulation of apoptosis; positive regulation of transcription, DNA-dependent; response to glucocorticoid stimulus; positive regulation of caspase activity; positive regulation of NF-kappaB import into nucleus; osteoclast differentiation; positive regulation of translational initiation by iron; positive regulation of membrane protein ectodomain proteolysis; activation of NF-kappaB transcription factor; positive regulation of MAP kinase activity; tumor necrosis factor-mediated signaling pathway; positive regulation of phagocytosis; negative regulation of interleukin-6 production; JNK cascade; negative regulation of osteoblast differentiation; positive regulation of action potential; embryonic gut development; regulation of immunoglobulin secretion; negative regulation of protein complex disassembly; response to drug; positive regulation of cytokine production; positive regulation of heterotypic cell-cell adhesion; positive regulation of I-kappaB kinase/NF-kappaB cascade; positive regulation of mitosis; response to virus; positive regulation of interleukin-8 biosynthetic process; glucose metabolic process; positive regulation of interleukin-6 production; negative regulation of fat cell differentiation; positive regulation of chemokine production; negative regulation of cytokine secretion during immune response; positive regulation of protein transport; cell activation; detection of mechanical stimulus involved in sensory perception of pain; defense response to Gram-positive bacterium; DNA damage response, signal transduction resulting in induction of apoptosis; induction of apoptosis via death domain receptors; positive regulation of transcription factor activity; positive regulation of transcription from RNA polymerase II promoter; response to activity; negative regulation of L-glutamate transport; negative regulation of transcription, DNA-dependent; skeletal muscle contraction; sequestering of triacylglycerol; positive regulation of smooth muscle cell proliferation; negative regulation of transcription from RNA polymerase II promoter; positive regulation of interleukin-18 production; chronic inflammatory response to antigenic stimulus; positive regulation of synaptic transmission; response to salt stress; positive regulation of hair follicle development; negative regulation of cell proliferation; response to radiation; negative regulation of lipid catabolic process; positive regulation of neuron apoptosis; lipopolysaccharide-mediated signaling pathway; protein kinase B signaling cascade; positive regulation of chronic inflammatory response to antigenic stimulus; regulation of I-kappaB kinase/NF-kappaB cascade; inflammatory response; caspase activation; positive regulation of humoral immune response mediated by circulating immunoglobulin; positive regulation of protein complex disassembly; transformed cell apoptosis; calcium-mediated signaling; MAPKKK cascade; positive regulation of peptidyl-serine phosphorylation; humoral immune response; positive regulation of protein kinase B signaling cascade; positive regulation of programmed cell death; positive regulation of interferon-gamma production; negative regulation of glucose import; positive regulation of protein complex assembly; positive regulation of chemokine biosynthetic process; negative regulation of viral genome replication; protein import into nucleus, translocation; positive regulation of protein kinase activity; activation of MAPKKK activity; response to hypoxia; positive regulation of fever; receptor biosynthetic process; positive regulation of protein amino acid phosphorylation; leukocyte tethering or rolling; negative regulation of myoblast differentiation; regulation of insulin secretion; positive regulation of cytokine secretion
Disease: Asthma, Susceptibility To; Migraine With Or Without Aura, Susceptibility To, 1; Malaria, Susceptibility To
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-TNF-alpha antibody
| Reference Product | PubMed Publications |
|---|---|
| TRAF2 antibody | >917 publications with TNF-alpha and TRAF2 |
| TNFRSF1A antibody | >351 publications with TNF-alpha and TNFRSF1A |
| IFNG antibody | >113 publications with TNF-alpha and IFNG |
| ADAM17 antibody | >112 publications with TNF-alpha and ADAM17 |
| TNFRSF1B antibody | >90 publications with TNF-alpha and TNFRSF1B |
| PRTN3 antibody | >45 publications with TNF-alpha and PRTN3 |
| CSF1 antibody | >15 publications with TNF-alpha and CSF1 |
| DCN antibody | >14 publications with TNF-alpha and DCN |
| ADAM9 antibody | >10 publications with TNF-alpha and ADAM9 |
| BGN antibody | >6 publications with TNF-alpha and BGN |
Pathways associated with anti-TNF-alpha antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipocytokine Signaling Pathway antibodies | Adipocytokine Signaling Pathway Diagram |
| Adipogenesis Pathway antibodies | Adipogenesis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| African Trypanosomiasis Pathway antibodies | African Trypanosomiasis Pathway Diagram |
| AhR Pathway antibodies | AhR Pathway Diagram |
| Allograft Rejection Pathway antibodies | Allograft Rejection Pathway Diagram |
| Allograft Rejection Pathway antibodies | Allograft Rejection Pathway Diagram |
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
| Alzheimer's Disease Pathway antibodies | Alzheimer's Disease Pathway Diagram |
Diseases associated with anti-TNF-alpha antibody
| Disease Name | Pubmed Publications |
|---|---|
| Necrosis Antibodies | >80591 publications with TNF-alpha and Necrosis |
| Inflammation Antibodies | >26751 publications with TNF-alpha and Inflammation |
| Vascular Diseases Antibodies | >6430 publications with TNF-alpha and Vascular Diseases |
| Lung Diseases Antibodies | >5841 publications with TNF-alpha and Lung Diseases |
| Skin Diseases Antibodies | >5017 publications with TNF-alpha and Skin Diseases |
| Liver Diseases Antibodies | >4388 publications with TNF-alpha and Liver Diseases |
| Fibrosis Antibodies | >2046 publications with TNF-alpha and Fibrosis |
| Insulin Resistance Antibodies | >2037 publications with TNF-alpha and Insulin Resistance |
| Atherosclerosis Antibodies | >1997 publications with TNF-alpha and Atherosclerosis |
| Pain Antibodies | >1814 publications with TNF-alpha and Pain |
Organs/Tissues associated with anti-TNF-alpha antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >45739 publications with TNF-alpha and Blood |
| Lung Antibodies | >8433 publications with TNF-alpha and Lung |
| Brain Antibodies | >5912 publications with TNF-alpha and Brain |
| Heart Antibodies | >4369 publications with TNF-alpha and Heart |
| Intestine Antibodies | >3060 publications with TNF-alpha and Intestine |
| Connective Tissue Antibodies | >1928 publications with TNF-alpha and Connective Tissue |
| Lymph Node Antibodies | >1763 publications with TNF-alpha and Lymph Node |
| Placenta Antibodies | >742 publications with TNF-alpha and Placenta |
| Prostate Antibodies | >714 publications with TNF-alpha and Prostate |
| Ovary Antibodies | >487 publications with TNF-alpha and Ovary |


